Update on the use of trandolapril in the management of cardiovascular disorders

References

• AgewallSWikstrandJLjungmanS1997Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study GroupAm J Cardiol8016499230153
   PubMed Web of Science ®Google Scholar
• AmannKIrzyniecTMallG1993The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysisJ Hypertens11969758254179
   PubMed Web of Science ®Google Scholar
• AndersonJLAdamsCDAntmanEM2007ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency MedicineJ Am Coll Cardiol50e1e15717692738
   PubMed Web of Science ®Google Scholar
• ArnerPWadeAEngfeldtP1994Pharmacokinetics and pharmacodynamics of trandolapril after repeated administration of 2 mg to young and elderly patients with mild-to-moderate hypertensionJ Cardiovasc Pharmacol23Suppl 4S4497527101
   PubMedGoogle Scholar
• AurellM1998The renin-angiotensin system: the centenary jubileeBlood Press77159657532
   PubMedGoogle Scholar
• BraunwaldEDomanskiMJFowlerSE2004Angiotensin-converting-enzyme inhibition in stable coronary artery diseaseN Engl J Med35120586815531767
   PubMed Web of Science ®Google Scholar
• BuchPRasmussenSAbildstromSZ2005The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 yearsEur Heart J261455215618070
   PubMed Web of Science ®Google Scholar
• CesaroneMRDe SanctisMTLauroraG1994Effects of trandolapril on 24-h ambulatory blood pressure in patients with mild-to-moderate essential hypertensionJ Cardiovasc Pharmacol23Suppl 4S65727527105
   PubMedGoogle Scholar
• ChobanianAVBakrisGLBlackHR2003The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA28925607212748199
   PubMed Web of Science ®Google Scholar
• CohnJNFerrariRSharpeN2000Cardiac remodeling – concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac RemodelingJ Am Coll Cardiol355698210716457
   PubMed Web of Science ®Google Scholar
• DanielsonBQuerinSLarochelleP1994Pharmacokinetics and pharmacodynamics of trandolapril after repeated administration of 2 mg to patients with chronic renal failure and healthy control subjectsJ Cardiovasc Pharmacol23Suppl 4S5097527102
   PubMedGoogle Scholar
• De LeeuwPWThijsLBirkenhagerWH2002Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trialJ Am Soc Nephrol1322132212191965
   PubMed Web of Science ®Google Scholar
• De LucaNRosielloGLamenzaF1992Reversal of cardiac and large artery structural abnormalities induced by long-term antihypertensive treatment with trandolaprilAm J Cardiol7052D59D
   PubMed Web of Science ®Google Scholar
• DiercksGFHillegeHLVan BovenAJ2002Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changesJ Am Coll Cardiol40140112392828
   PubMed Web of Science ®Google Scholar
• FoxKM2003Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)Lancet362782813678872
   PubMed Web of Science ®Google Scholar
• FurbergCDPittB2001Are all angiotensin-converting enzyme inhibitors interchangeable?J Am Coll Cardiol3714566011300461
   PubMed Web of Science ®Google Scholar
• GallMARossingPSkottP1991Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patientsDiabetologia34655611955098
   PubMed Web of Science ®Google Scholar
• GersteinHCMannJFYiQ2001Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individualsJAMA286421611466120
   PubMed Web of Science ®Google Scholar
• GrangerCBCaliffRMYoungS1993Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupJ Am Coll Cardiol2192058450161
   PubMedGoogle Scholar
• GrossMLHeissNWeckbachM2004ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetesDiabetologia473162414727024
   PubMed Web of Science ®Google Scholar
• GuayDRP2003Trandolapril: A newer angiotensin-converting enzyme inhibitorClin Ther257137512852701
   PubMed Web of Science ®Google Scholar
• GullerBHallJReevesRL1993Cardiac effects of trandolapril in hypertensionAm Heart J1251536418480626
   PubMed Web of Science ®Google Scholar
• GustafssonFTorp-PedersenCKoberL1997Effect of angioten-sin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension. TRACE Study Group, Trandolapril Cardiac EventJ Hypertens1579389222948
   PubMed Web of Science ®Google Scholar
• GustafssonITorp-PedersenCKoberL1999Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study GroupJ Am Coll Cardiol3483910399995
   PubMed Web of Science ®Google Scholar
• HansenMLGislasonGHKoberL2008Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarctionBr J Clin Pharmacol652172317711535
   PubMed Web of Science ®Google Scholar
• HednerTHanssonLHimmelmannA1998The renin-angiotensin system – a century of progressBlood Press768709657531
   PubMedGoogle Scholar
• HegerJJWeymanAEWannLS1980Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarctionCirculation61111387371123
   PubMed Web of Science ®Google Scholar
• HOPE Study Investigators2000Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study InvestigatorsLancet355253910675071
   PubMed Web of Science ®Google Scholar
• HuntSAAbrahamWTChinMH2005ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm SocietyCirculation112e15423516160202
   PubMed Web of Science ®Google Scholar
• Kalus JSColemanCIWhiteCM2006The impact of suppressing the renin-angiotensin system on atrial fibrillationJ Clin Pharmacol4621816397280
   PubMed Web of Science ®Google Scholar
• KawataTDaimonMHasegawaR2006Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonistAm Heart J151798e91516569537
   PubMedGoogle Scholar
• KellerCKBergisKHFliserD1996Renal findings in patients with short-term type 2 diabetesJ Am Soc Nephrol72627358989741
   PubMed Web of Science ®Google Scholar
• KoberLTorp-PedersenCCarlsenJE1995A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study GroupN Engl J Med333167067477219
   PubMed Web of Science ®Google Scholar
• LjungmanSWikstrandJHartfordM1996Urinary albumin excretion – a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive menAm J Hypertens977088862223
   PubMed Web of Science ®Google Scholar
• MakKHMoliternoDJGrangerCB1997Influence of diabetes mel-litus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesJ Am Coll Cardiol3017199207639
   PubMed Web of Science ®Google Scholar
• MalikRA2000Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?Ann Med321510711571
   PubMed Web of Science ®Google Scholar
• MalikRAWilliamsonSAbbottC1998Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trialLancet3521978819872248
   PubMed Web of Science ®Google Scholar
• MalmbergKRydenLHamstenA1996Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial InfarctionEur Heart J171337448880018
   PubMedGoogle Scholar
• ManciaGDe CesarisRFogariR1992Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study GroupAm J Cardiol7060D66D1615871
   PubMed Web of Science ®Google Scholar
• MeyerBHMullerFOBadenhorstPN1995Multiple doses of trandolapril do not affect warfarin pharmacodynamicsS Afr Med J85768708553147
   PubMed Web of Science ®Google Scholar
• MiettinenHHaffnerSMLehtoS1996Proteinuria predicts stroke and other atherosclerotic vascular disease events in non-diabetic and non-insulin-dependent diabetic subjectsStroke27203398898811
   PubMed Web of Science ®Google Scholar
• NewJPBilousRWWalkerM2000Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days‘ treatment with trandolaprilDiabet Med171344010746484
   PubMed Web of Science ®Google Scholar
• OmboniSRavogliAVillaniA1995Permanent blood pressure control over the 24 h by trandolaprilAm J Hypertens871S74S8845088
   PubMed Web of Science ®Google Scholar
• PalardyMDucharmeA2005Inhibition of the renin-angiotensin system and prevention of atrial fibrillation in heart failureHeart Drug52149
   Google Scholar
• PedersenODAbildstromSZOttesenMM2006Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarctionEur Heart J27290516267070
   PubMed Web of Science ®Google Scholar
• PedersenODBaggerHKoberL1999Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunctionCirculation1003768010421597
   PubMed Web of Science ®Google Scholar
• PepineCJHandbergEMCooper-DehoffRM2003A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trialJAMA29028051614657064
   PubMed Web of Science ®Google Scholar
• PetrieJRMorrisADUedaS2000Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trialJ Clin Endocrinol Metab851882910843169
   PubMed Web of Science ®Google Scholar
• PittB2004ACE inhibitors for patients with vascular disease without left ventricular dysfunction – may they rest in PEACE?N Engl J Med3512115715531768
   PubMed Web of Science ®Google Scholar
• PROCOPA2002Dissociation between blood pressure reduction and fall in proteinuria in primary renal disease: a randomized double-blind trialJ Hypertens207293711910310
   PubMed Web of Science ®Google Scholar
• RavidMBroshDRavid-SafranD1998Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemiaArch Intern Med15899810049588433
   PubMed Web of Science ®Google Scholar
• RemuzziAPuntorieriSBattagliaC1990Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the ratJ Clin Invest8554191688888
   PubMed Web of Science ®Google Scholar
• RenelandRAlvarezEAnderssonPE2000Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolaprilJ Hum Hypertens141758010694831
   PubMed Web of Science ®Google Scholar
• RuggenentiPFassiAIlievaAP2004Preventing microalbuminuria in type 2 diabetesN Engl J Med35119415115516697
   PubMed Web of Science ®Google Scholar
• SarnakMJLeveyASSchoolwerthAC2003Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and PreventionCirculation10821546914581387
   PubMed Web of Science ®Google Scholar
• SongJCWhiteCM2002Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an updateClin Pharmacokinet412072411929321
   PubMed Web of Science ®Google Scholar
• StoschitzkyK1999Trandolapril and human diabetic neuropathyLancet353926710094009
   PubMedGoogle Scholar
• SwedbergKClelandJDargieH2005Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of CardiologyEur Heart J2611154015901669
   PubMed Web of Science ®Google Scholar
• TRACE1994The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. The Trace Study GroupAm J Cardiol7344C50C
   PubMed Web of Science ®Google Scholar
• TytusRHBurgessEDAssoulineL2007A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL)Clin Ther293051517472822
   PubMed Web of Science ®Google Scholar
• Van Der EntMRemmeWJDe LeeuwPW1998Renal hemodynamic effects in patients with moderate to severe heart failure during chronic treatment with trandolaprilCardiovasc Drugs Ther123954039825186
   PubMed Web of Science ®Google Scholar
• WisemanLRMcTavishD1994Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertensionDrugs4871907525196
   PubMed Web of Science ®Google Scholar
• YusufSSleightPPogueJ2000Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med3421455310639539
   PubMed Web of Science ®Google Scholar
• ZuanettiGLatiniRMaggioniAP1993Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 studyJ Am Coll Cardiol221788948245329
   PubMed Web of Science ®Google Scholar